SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • November 8th, 2011 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 8th, 2011 Company Industry JurisdictionTHIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of September 1, 2011 (the “Effective Date”) is entered into by and between G. Charles Robb, Chief Financial Officer (“CFO”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).